Acadia Pharmaceuticals
James Nelson is a seasoned leader in Quality Assurance with extensive experience in the pharmaceutical industry, currently serving as Vice President of Quality at Acadia Pharmaceuticals Inc. since April 2023, where oversight of quality operations for commercial drug products and late-stage therapies takes priority. Previously, James was Vice President of Quality Assurance and Compliance at Nurix Therapeutics, directing quality strategy for oncology clinical trials, and held Vice President roles at Neurocrine Biosciences, driving quality initiatives for major product launches. Earlier in a career at Arena Pharmaceuticals, James advanced from Executive Director of Quality Assurance to Associate Vice President of Quality Systems, optimizing quality practices across the organization. James's foundational experience began at Seres Laboratories Inc., where roles spanned from Director of Quality Assurance and Quality Control to Quality Assurance Specialist. Educational qualifications include Bachelor of Arts degrees in Chemistry and Biology from Sonoma State University.
This person is not in any teams
This person is not in any offices
Acadia Pharmaceuticals
3 followers
Acadia is trailblazing breakthroughs in neuroscience to elevate life. They are at the forefront of healthcare, fighting for breakthroughs in our science, their therapies and the way we work, but also in the lives of the people they serve. Acadia is committed to their purpose: we fight disease so more you shines through.